Golden State Equity Partners Ocular Therapeutix, Inc Transaction History

Golden State Equity Partners

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 01, 2023	SELL	$2.79 - $6.27 $145,777 - $327,607	-52,250 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$4.83 - $7.35 $252,367 - $384,037	52,250 New	52,250 $259,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $251,884 - $383,302	-52,150 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$6.16 - $12.07 $122,522 - $240,072	19,890 Added 61.66%	52,150 $363,000
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $182,942 - $270,452	18,860 Added 140.75%	32,260 $323,000

Q2 2021 Aug 12, 2021	BUY	$13.43 - $19.16 $179,962 - $256,744	13,400 New	13,400 $190,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Golden State Equity Partners, based on Form 13F filings with the SEC.

Stay updated on Golden State Equity Partners with notifications on news.